SoftBank-backed Neumora's shares fall in Nasdaq debut

Neumora Therapeutics

15/09/2023 17:31

Sept 15 (Reuters) - Neumora Therapeutics  NMRA.O , which
is backed by Amgen and Japan's SoftBank, fetched a valuation of
$2.51 billion in its Nasdaq debut after its shares fell nearly
3% on Friday.
    Neumora had priced its shares at $17 apiece.
    
    

 (Reporting by Jaiveer Shekhawat and Pritam Biswas in Bengaluru;
Editing by Shounak Dasgupta)
 ((JaiveerSingh.Shekhawat@thomsonreuters.com))